US2017042961A1PendingUtilityA1

Methods for treating hcv

50
Assignee: GILEAD SCIENCES INCPriority: Dec 20, 2010Filed: Aug 23, 2016Published: Feb 16, 2017
Est. expiryDec 20, 2030(~4.4 yrs left)· nominal 20-yr term from priority
A61P 31/12A61P 43/00A61P 31/14A61K 31/4436A61K 31/7068A61K 31/675A61K 31/7056A61P 1/16A61K 31/5377A61K 31/4025A61K 31/4184A61K 31/4188A61K 31/381A61K 31/407A61K 31/401A61K 31/4178A61K 38/05A61K 45/06A61K 31/40A61K 31/706A61K 38/212A61K 31/662A61K 31/501A61K 31/4353
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

Claims

exact text as granted — not AI-modified
1 . A composition comprising two or more compounds selected from Compound 1, Compound 2, Compound 3, Compound 4, Compound 5, Compound 6 and Compound 7: 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt of Compound 1, Compound 2, Compound 3, Compound 4, Compound 5, Compound 6 and Compound 7, 
         provided that Compound 1 and Compound 2 are not the only compounds in the composition and further provided that Compound 1 and Compound 3 are not the only compounds in the composition. 
       
     
     
         2 . The composition of  claim 1  which comprises Compound 1 and further comprises a second compound selected from the group consisting of Compound 2, Compound 3, Compound 4, Compound 5, Compound 6 and Compound 7. 
     
     
         3 . The composition of  claim 2 , wherein the second compound is Compound 4. 
     
     
         4 . The composition of  claim 2 , wherein the second compound is Compound 5. 
     
     
         5 . The composition of  claim 2 , wherein the second compound is Compound 6. 
     
     
         6 . The composition of  claim 1  which comprises Compound 2 and further comprises a second compound selected from the group consisting of Compound 1, Compound 3, Compound 4, Compound 5, Compound 6 and Compound 7. 
     
     
         7 . The composition of  claim 6 , wherein the second compound is Compound 4. 
     
     
         8 . The composition of  claim 1  which comprises Compound 3 and further comprises a second compound selected from the group consisting of Compound 1, Compound 2, Compound 4, Compound 5, Compound 6 and Compound 7. 
     
     
         9 . The composition of  claim 8 , wherein the second compound is Compound 1. 
     
     
         10 . The composition of  claim 8 , wherein the second compound is Compound 5. 
     
     
         11 . The composition of  claim 8 , wherein the second compound is Compound 6. 
     
     
         12 . The composition of  claim 1  which comprises Compound 4 and further comprises a second compound selected from the group consisting of Compound 1, Compound 2, Compound 3, Compound 5, Compound 6 and Compound 7. 
     
     
         13 . The composition of  claim 12 , wherein the second compound is Compound 1. 
     
     
         14 . The composition of  claim 12 , wherein the second compound is Compound 2. 
     
     
         15 . The composition of  claim 12 , wherein the second compound is Compound 3. 
     
     
         16 . The composition of  claim 12 , wherein the second compound is Compound 6. 
     
     
         17 . The composition of  claim 1  which comprises Compound 5 and further comprises a second compound selected from the group consisting of Compound 1, Compound 2, Compound 3, Compound 4, Compound 6 and Compound 7. 
     
     
         18 . The composition of  claim 17 , wherein the second compound is Compound 1. 
     
     
         19 . The composition of  claim 17 , wherein the second compound is Compound 3. 
     
     
         20 . The composition of  claim 17 , wherein the second compound is Compound 6. 
     
     
         21 - 211 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.